Track Insight Molecular Diagnostics's goodwill ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), IMDX shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IMDX's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Insight Molecular Diagnostics is outperforming or lagging.
Tracking IMDX's goodwill over time shows whether Insight Molecular Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Insight Molecular Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.
Insight Molecular Diagnostics's goodwill is $0; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.